Papers
2
Total Citations
141
H-Index
2
About
Dr. Hua Xu is a leading figure in urologic oncology, whose work has fundamentally shaped the evidence base for robotic surgery. His research centers on comparing the efficacy and safety of minimally invasive robotic techniques against traditional open surgery for major cancers. Dr. Xu’s most impactful contributions are landmark systematic reviews and meta-analyses that have guided clinical practice. His 2014 study on robotic versus open radical cystectomy for bladder cancer, cited 76 times, provided critical early evidence on perioperative outcomes. He further solidified this foundation with a 2016 meta-analysis update on robotic-assisted radical prostatectomy (RARP) versus retropubic radical prostatectomy (RRP), cited 65 times. This work synthesized large-scale, high-quality data to clarify the debated safety and feasibility of RARP, offering a more valid assessment for surgeons worldwide. By rigorously aggregating evidence, Dr. Xu has not only advanced the field of urologic oncology but also empowered clinicians with the data needed to make informed, patient-centered decisions, cementing his role as a key architect of modern surgical standards.
Research Focus
Key Achievements
Top Papers
- 1
- 2